US Broker Ratings

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a 12.95% Potential Upside

As a titan in the healthcare industry, Johnson & Johnson (NYSE: JNJ) continues to capture the attention of investors with its robust market presence and promising..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 31.67% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX) stands as a notable entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant Shows 5.22% Potential Upside

McKesson Corporation (NYSE: MCK) stands as a towering presence in the healthcare sector, with its influence spanning both the United States and international markets. As a..

UnitedHealth Group (UNH) Stock Analysis: Examining a 27.77% Upside Potential

UnitedHealth Group Incorporated (UNH), a titan in the healthcare plans industry, continues to capture the attention of investors with its robust market presence and diverse service..

Pfizer, Inc. (PFE) Stock Analysis: A 21.98% Potential Upside Amid Strong Dividend Yield

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to capture investor attention with its expansive portfolio of biopharmaceutical products and an enticing dividend..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a Potential 113.95% Upside in the Healthcare Sector

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector specializing in preparedness and response solutions, offers investors a compelling opportunity with a potential..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Assessing a 217% Potential Upside in the Biotech Sector

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with its promising position in the biotechnology sector, particularly within the healthcare industry. As a..

Standard BioTools Inc. (LAB) Stock Analysis: A 117.89% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB), a prominent player in the healthcare sector, is garnering attention from investors due to its potential upside of 117.89%, as indicated..

Celcuity Inc. (CELC) Stock Analysis: A Promising 141% Upside Potential in Biotechnology

Celcuity Inc. (NASDAQ: CELC) is making waves in the biotechnology sector with its innovative approach to targeted cancer therapies. This clinical-stage biotech company, headquartered in Minneapolis,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a 263.81% Potential Upside with Innovative Peptide Therapies

MBX Biosciences, Inc. (NASDAQ: MBX) is attracting significant attention in the biotechnology sector, particularly due to its impressive potential upside of 263.81%, as projected by analysts...

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech Gem with 104.99% Potential Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the biotechnology sector with a notable promise for investors, demonstrated by its potential upside of 104.99%. As a..

Abivax SA (ABVX): Exploring a 513.93% Potential Upside in Biotech Innovation

Abivax SA (ABVX), a clinical-stage biotechnology company based in Paris, is making waves in the healthcare sector with its ambitious focus on chronic inflammatory diseases. With..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 103.87% Potential Upside

Investors with an eye on the healthcare sector may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect. Specializing in regenerative medicine, this company develops and..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a 4.90% Potential Upside Amidst Volatility

Ginkgo Bioworks Holdings, Inc. (DNA), a pioneering name in the biotechnology sector, has been catching investor attention as it navigates the intricate corridors of cell programming..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A High-Potential Biotech Play with 238% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA) is attracting significant attention in the biotechnology sector with an impressive potential upside of 238.16%. This Seattle-based company is pioneering the..

Prothena Corporation plc (PRTA): Significant Upside Potential with a 322% Growth Outlook

Prothena Corporation plc (NASDAQ: PRTA), a Dublin-based biotechnology company, has caught the attention of investors with its remarkable potential upside of over 322%, as indicated by..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 91.81% Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a notable player in the healthcare sector, specializes in innovative medical devices aimed at alleviating pain and addressing musculoskeletal therapies. With a..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 104% Potential Upside in the Healthcare Sector

Navigating the complex landscape of biopharmaceutical investments can be daunting for many individual investors, but Kamada Ltd. (NASDAQ: KMDA) currently offers a compelling opportunity that warrants..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Bold 245% Upside Awaits Investors in Cutting-Edge Biotech

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the spotlight in the biotechnology sector with its innovative approach to immunology-based therapies. Founded in 2019 and headquartered in..

Surmodics, Inc. (SRDX) Investor Outlook: Navigating Challenges in the Healthcare Sector

For investors keeping a keen eye on the healthcare sector, Surmodics, Inc. (NASDAQ: SRDX) presents a fascinating case within the medical devices industry. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds